PathSensors announces the addition of Dr. David Hodge as a member of their Scientific Advisory Board. Dr. Hodge is currently an Affiliate member of the Pathogen and Microbiome Institute (PMI) at the Northern Arizona University (NAU) in Flagstaff, Arizona. Prior to...read more
PathSensors Secures 5-year Department of Defense Contract for Building Protection
Baltimore, November 20th, 2018 – PathSensors, Inc., a rapidly growing, Baltimore-based biotechnology company focused on delivering pathogen detection solutions, announced today that it has been awarded a $7.2 million contract from the Department of Defense – Washington Headquarters Services to provide CANARY reagents and technical support to Department of Defense Facilities in the National Capital Region. The program includes the manufacture of reagents, equipment support and the development of products for new and emerging threats. The contract extends through 2023.
“We are honored to be of support to such a significant organization,” said Ted Olsen, President and CEO of PathSensors. “We have a longstanding relationship with the Department of Defense and this contract reflects the value of CANARY as an industry leader in bio detection.”
PathSensors has worked in the building security markets since 2007. Most recently, the company has expanded into worldwide food safety and agricultural applications.
PathSensors is a privately held biotechnology company deploying proprietary CANARY technology, exclusively licensed from MIT-Lincoln Laboratory. PathSensors technology has been designed to detect extremely low levels of biological threats in minutes. Additional information is available at http://www.PathSensors.com.
Sales and Marketing